The use of intravenous immunoglobulins in the treatment of neuromuscular disorders.
Intravenous immunoglobulin is increasingly used in the treatment of neuromuscular disorders. Its efficacy has been proven in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and Lambert-Eaton myasthenic syndrome. In addition, there is increasing evidence that it has beneficial effects in other neuromuscular disorders.
Department of Neurology, Klinikum Grosshadern, University of Munich, Germany.
R
R
Voltz
R
R
Hohlfeld
D004334:Drug Administration Schedule; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology / Q000627:therapeutic use*; D009468:Neuromuscular Diseases / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous